Intra-Cellular Therapies Inc.

Q2 2019 13F Holders

Symbol
ITCI
CUSIP
46116X101
Type
Equity
Class
COM
Num filers
137
Total reported value, excl. options
$498M
Manager Report Date Value ($000) Shares Option Type